BioReference initiates COVID-19 testing for all Major League Soccer players, match officials, and Club and League employees participating in the MLS is Back Tournament MLS will support COVID-19 antibody testing for the Orlando community utilizing BioReference’s community collection program ELMWOOD PARK, N.J., July 09, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), will […]
Based on internal data, 29% of nursing home employees tested positive for antibodies Since the beginning of the COVID-19 pandemic, BioReference has performed 222,000 COVID-19 PCR and 3,500 antibody tests in over 350 facilities ELMWOOD PARK, N.J., July 1, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR […]
Collaboration supports return-to-work planning for key workforce groups NEW YORK (May 18, 2020) – MagnaCare today announced a collaboration with BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), to bring COVID-19 antibody testing to their Labor clients in the New York metropolitan area. Through this collaboration with BioReference, MagnaCare will offer on-site antibody blood […]
13
May
May
ELMWOOD PARK, N.J., May 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a strategic collaboration with the Westchester Medical Center Health Network (WMCHealth), a 1,700-bed healthcare system headquartered in Valhalla, New York, to provide full laboratory administrative services, laboratory operations, reference testing and outpatient laboratory services. WMCHealth has 10 hospitals […]
08
May
May
In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing ELMWOOD PARK, N.J., May 8, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health […]
29
Apr
Apr
BioReference will broaden availability of serological antibody tests to states, hospitals and healthcare organizations throughout the United States ELMWOOD PARK, N.J., April 29, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Antibody testing […]
28
Apr
Apr
Sexually transmitted infections or STIs, also referred to as sexually transmitted diseases or STDs, are common in men and women. April is STD/STI Awareness Month, so there is no time like the present to talk with your sexual partner(s) and get tested. Did You Know? There are approximately 20 million new STI cases each year […]
21
Apr
Apr
It is Medical Laboratory Professionals Week – the annual celebration of the medical laboratory professionals and pathologists who play a vital role in health care and patient advocacy. This year, in the midst of the COVID-19 pandemic, lab professionals around the world have been working extremely hard and deserve special recognition. What is Medical Laboratory […]
20
Apr
Apr
GeneDx’s Gaithersburg and BioReference’s Melbourne facilities offer COVID-19 testing ELMWOOD PARK, N.J., April 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced its subsidiary GeneDx will begin testing for COVID-19 to further expand public access to testing. In addition, BioReference will leverage its Melbourne, Florida facility to increase COVID-19 testing capacity, […]
06
Apr
Apr
ELMWOOD PARK, N.J., April 6, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. “Our goal is to maintain the current 24 hour turnaround time for these patients,” said Jon R. Cohen, M.D., Executive Chairman of […]
- 1
- 2